Scilex Holding Company (SCLX) Revenue History
Annual and quarterly revenue from 2020 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SCLX Revenue Growth
SCLX Revenue Analysis (2020–2024)
As of May 8, 2026, Scilex Holding Company (SCLX) generated trailing twelve-month (TTM) revenue of $40.4 million, reflecting significant decline in growth of -26.8% year-over-year. The most recent quarter (Q3 2025) recorded $10.6 million in revenue, up 6.7% sequentially.
Looking at the longer-term picture, SCLX's historical revenue data shows a 3-year CAGR of +21.8%. The company achieved its highest annual revenue of $56.6 million in 2024, representing a new all-time high.
When compared to Healthcare sector peers including PAHC (+32.4% YoY), HRMY (+20.7% YoY), and PRGO (-3.6% YoY), SCLX has underperformed the peer group in terms of revenue growth. Compare SCLX vs PAHC →
SCLX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SCLXCurrent | $40M | -26.8% | - | -147.4% | |
 PAHC | $1.3B | +32.4% | +10.1% | 8.5% | |
 HRMY | $868M | +20.7% | +40.3% | 24.0% | |
 PRGO | $4.3B | -3.6% | +0.8% | 8.1% | |
 SUPN | $719M | +16.3% | +6.7% | -5.1% | |
 COLL | $781M | +19.9% | +20.3% | 24.0% |
SCLX Historical Revenue Data (2020–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $56.6M | +21.1% | $39.9M | 70.5% | $-83,396,000 | -147.4% |
| 2023 | $46.7M | +22.9% | $31.1M | 66.5% | $-105,431,000 | -225.6% |
| 2022 | $38.0M | +21.4% | $27.2M | 71.6% | $-50,634,000 | -133.1% |
| 2021 | $31.3M | +32.9% | $27.7M | 88.4% | $-35,838,000 | -114.4% |
| 2020 | $23.6M | - | $21.4M | 90.9% | $-35,258,000 | -149.7% |
See SCLX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SCLX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SCLX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSCLX — Frequently Asked Questions
Quick answers to the most common questions about buying SCLX stock.
Is SCLX's revenue growth accelerating or slowing?
SCLX revenue declined -26.8% year-over-year, contrasting with the 5-year CAGR of N/A. TTM revenue fell to $40M. This reverses the prior growth trend.
What is SCLX's long-term revenue growth rate?
Scilex Holding Company's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of -26.8% is below this long-term average.
How is SCLX's revenue distributed by segment?
SCLX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2024 are available for download. Segment mix reveals concentration and diversification trends.